Functional and structural cardiac alterations associated with β-adrenergic chronic stimulation. Role of aldosterone

University College London 2006 (2006) Proc Physiol Soc 3, PC82

Poster Communications: Functional and structural cardiac alterations associated with β-adrenergic chronic stimulation. Role of aldosterone

B. Martín-Fernández1, A.P. Couto-Davel2, M. Miana1, N. de las Heras1, D. Sanz-Rosa1, L.V. Rossoni2, V. Lahera1, V. Cachofeiro1

1. Physiology, School of Medicine, Universidad Complutense, Madrid, Spain. 2. Pharmacology, Institute of Biomedical Science, University of Sao Paulo, Sao Paulo, Brazil.

View other abstracts by:


Several studies have reported that chronic β-adrenergic stimulation is associated with functional cardiac alterations as well as ventricular hypertrophy. It is well known that aldosterone is a profibrotic factor which participates in the development of ventricular hypertrophy and heart failure. However, the participation of aldosterone in cardiac alterations produced by chronic stimulation of β-adrenergic receptors is not established. Therefore, the aim of this study was to evaluate the cardiac effects of an antagonist of mineralocorticoid receptors in rats with chronic stimulation of β-adrenergic receptors. To this end, male Wistar rats (250g), N=6 in each group, were treated with either isoproterenol (ISO; 3mg/kg/day s.c.) or vehicle for 15 days. Half of the animals from each group were treated with spironolactone (SPIRO; 200mg/Kg/day s.c). At the end of the treatment, heart rate (HR) was measured. In addition, systolic arterial pressure (SAP), diastolic (DAP) and mean (MAP), left ventricle final diastolic pressure (pDf), + dP/dt and – dP/dt were measured through a catheter inserted into the right carotid artery. Animals were anesthesiced with ketamine (0.07ml/100mg body weight) and Xilacyne (0.03ml/100mg corporal weight) by intraperitoneal injection. Also, cardiomyocytes diameter and collagen content present in the miocardium was evaluated with optical microscopy techniques. As index of cardiac hypertrophy, the ratio heart/body weight was calculated. Neither ISO nor SPIRO were able to modify SAP, DAP, MAP, HR, + dP/dt y – dp/dt. However, pDf was higher (p<0.001) in rats treated with ISO as compared with controls. Treatment with SPIRO normalized these values (p<0.001). Relative heart weight was greater in the rats treated with ISO (p<0.001) than in controls. Treatment with SPIRO reduced heart weight (p<0.01) without becoming normalized. No differences in cardiomyocyte diameter were observed in any group. Collagen content in the myocardium of rats treated with ISO was greater (p<0.001) than in control rats. Treatment with SPIRO reduced collagen content (p<0.05) without reaching levels observed in controls. In conclusion, these data suggest that chronic stimulation of β-adrenergic receptors in rats induces diastolic dysfunction and cardiac hypertrophy associated with an increase in extracellular matrix. Aldosterone participates in these alterations.



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type